Jinpeng Su

Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection

P. Knolle, U. Protzer, K. Steiger, 2019, Scientific Reports.

Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-titer HBV Carrier Mice.

S. Milstein, D. Grimm, M. Heikenwalder, 2020, Gastroenterology.

Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.

U. Protzer, A. Kosinska, J. Festag, 2021, Antiviral research.

Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses

Jianping Ding, Hualan Chen, Yanbing Li, 2016, Nature Communications.

Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance

J. Altrichter, U. Protzer, A. Kosinska, 2022, JHEP reports : innovation in hepatology.

A thermostable therapeutic vaccine is able to break immune tolerance in a mouse model of chronic hepatitis B

J. Altrichter, U. Protzer, A. Kosinska, 2022, JHEP Reports.

Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.

P. Knolle, F. Thiele, U. Protzer, 2022, Journal of hepatology.

Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection

P. Knolle, U. Protzer, K. Steiger, 2019, Scientific Reports.

FRI-209-Exploring TH1/TH2 adjuvants to improve the efficacy of the therapeutic vaccination against chronic hepatitis B

F. Thiele, A. Kosinska, K. Singethan, 2019, Journal of Hepatology.

Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice.

G. Carnell, M. Breunig, David Peterhoff, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.